Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special PopulationsCHIEN, Jenny Y; HO, Rodney J. Y.Journal of pharmaceutical sciences. 2011, Vol 100, Num 1, pp 53-58, issn 0022-3549, 6 p.Article

Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceISOHERRANEN, Nina; YAGEN, Boris; SPIEGELSTEIN, Ofer et al.British journal of pharmacology. 2003, Vol 139, Num 4, pp 755-764, issn 0007-1188, 10 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracuriumCHEN, C; YAMAGUCHI, N; VARIN, F et al.British journal of anaesthesia. 2008, Vol 101, Num 6, pp 788-797, issn 0007-0912, 10 p.Article

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteersGASCON, A. R; CUADRADO, A; SOLINIS, M. A et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 309-315, issn 0946-1965, 7 p.Article

Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteersGEORGARAKIS, M; ZOUGROU, F; TZAVARA, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 316-322, issn 0946-1965, 7 p.Article

Pharmacogenomics and drug responseMÜLLER, M.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 231-240, issn 0946-1965, 10 p.Article

Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failurePODER, P; EHA, J; SUNDBERG, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 8, pp 365-373, issn 0946-1965, 9 p.Article

Ritonavir-enhanced pharmacokinetics of Nelfinavir/M8 during rifampin useBERGSHOEFF, Alina S; WOLFS, Tom F. W; GEELEN, Sibyl P. M et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 521-525, issn 1060-0280, 5 p.Article

Pharmacokinetics and pharmacodynamics of cisplatin after intra-operative Hyperthermic intraperitoneal chemoperfusion (HIPEC)ZEAMARI, S; FLOOT, B; VAN DER VANGE, N et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1643-1648, issn 0250-7005, 6 p.Article

Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteersNIOPAS, I; DAFTSIOS, A. C; NIKOLAIDIS, N et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 5, pp 226-230, issn 0946-1965, 5 p.Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Lack of interaction between HEPP, a New antiepileptic agent, and carbamazepine in rabbitsGARCIA, A. Luis; MEDINA, R. Liz; PEREZ, M. Rodolfo et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 205-209, issn 0142-2782, 5 p.Article

The effect of rifampin on the pharmacokinetics of vinorelbine in the micropigLEVEOUE, Dominique; WISNIEWSKI, Sandra; RENAULT, Corinne et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2741-2744, issn 0250-7005, 4 p.Article

Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programsFINKELSTEIN, Yaron; NAVA-DCAMPO, Alejandro A; SCHECHTER, Tal et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 53-57, issn 0767-3981, 5 p.Article

Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B₄ synthesis inhibitorTROCONIZ, Inaki F; ZSOLT, Ilonka; GARRIDO, Maria J et al.Pharmaceutical research. 2006, Vol 23, Num 7, pp 1533-1542, issn 0724-8741, 10 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokersCRONENBERGER, Carol; MOULD, Diane R; ROETHIG, Hans-Juergen et al.British journal of clinical pharmacology. 2008, Vol 65, Num 1, pp 30-39, issn 0306-5251, 10 p.Article

Population pharmacokinetics. III: Design, analysis, and application of population pharmacokinetic studiesETTE, Ene I; WILLIAMS, Paul J; LANE, James R et al.The Annals of pharmacotherapy. 2004, Vol 38, Num 12, pp 2136-2144, issn 1060-0280, 9 p.Article

Suitability of cefotiam and cefuroxime axetil for the perioperative short-term prophylaxis in tonsillectomy patientsMÜLLER, Rainer; BÖTTGER, Christina; WICHMANN, Georg et al.Arzneimittel-Forschung. 2003, Vol 53, Num 2, pp 126-132, issn 0004-4172, 7 p.Article

Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjectsWOJCICKI, Jerzy; JAROSZYNSKA, Maria; DROZDZIK, Marek et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 211-218, issn 0142-2782, 8 p.Article

Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakesSETCHELL, Kenneth D. R; BROWN, Nadine Maynard; DESAI, Pankaj B et al.The Journal of nutrition. 2003, Vol 133, Num 4, pp 1027-1035, issn 0022-3166, 9 p.Article

Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentanVAN GIERSBERGEN, P. L. M; DINGEMANSE, J.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 261-266, issn 0946-1965, 6 p.Article